Gene Delivery Using Viral Vectors - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 263

[111] Vincent K, Piraino ST, Wadsworth SC. Analysis of recombinant adeno-associated
virus packaging and requirements for rep and cap gene poducts. J Virol 1997;71:
1897-905.
[112] Li J, Samulski RJ, Xiao X. Role for highly regulated rep gene expression in adenoas-
sociated virus vector production. J Virol 1997;71:5236-43.
[113] Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus
vectors in the absence of helper adenovirus. J Virol 1998;72:2224-33.
[114] Matushita T, Elliger S, Elliger C, Podskaoff G, Villareal L, Kurtzman GJ, et al. Adeno-
associated virus vectors can be efficiently produced without helper virus. Gene Ther
1998;5:938-45.
[115] Grimm D, Kern A, Rittnet K, Kleinschmidt JA. Novel tools for production and purifica-
tion of recombinant adeno-associated virus vectors. Hum Gene Ther 1998;9:2745-60.
[116] Samulski RJ, Chang LS, Shenk TE. Helper-free stocks of recombinant adenoas-
sociated viruses: normal integration does not require viral gene expression. J Virol
1989;63:3822-8.
[117] Flotte TR, Barrazza-Ortiz X, Solow R, Afione SA, Carter BJ, Guggino WB. An
improved system for packaging recombinant adeno-associated virus vectors capable of
in vivo transduction. Gene Ther 1995;2:39-47.
[118] Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR. Cell lines for the production of
recombinant adeno-associated virus. Hum Gene Ther 1995;6:1329-41.
[119] Liu X, Voulgaropoulou F, Chen R, Johnson PR, Clark KR. Selective rep-cap gene
amplifications as a mechanism for high-titer recombinant AAV production from stable
cell lines. Mol Ther 2000;2:394-403.
[120] Gao GP, Qu G, Faust LZ, Engdahl RK, Xiao W, Hughes JV, et al. High-titer adeno-
associated viral vectors from a rep/cap cell line and hybrid shuttle virus. Hum Gene
Ther 1998;9:2353-62.
[121] Liu XL, Clark KR, Johnson PR. Production of recombinant adeno-associated virus
vectors using a packaging cell line and a hybrid recombinant virus. Gene Ther
1999;6:293-99.
[122] Inoue I, Russell DW. Packaging cells based on inducible gene amplification for the pro-
duction of adeno-associated virus vectors. J Viro 1998;72:7024-31.
[123] Conway JE, Zolotukhin S, Muzyczka N, Hayward GS, Byrne BJ. Recombinant adeno-
associated virus type 2 replication and packaging is entirely supported by a herpes sim-
plex virus type 1 amplicon expressing rep and cap. J Virol 1997;71:8780-9.
[124] Conway JE, Rhys CMJ, Zolotukhin I, Zolotukhin S, Muzyczka N, Hayward GS,
et al. High-titer recombinant adeno-associated virus production utilizing a recom-
binant herpes simplex virus type 1 vector expressing AAV-2 rep and cap. Gene Ther
1999;6:86-993.
[125] Fisher KJ, Kelley WM, Burda JF, Wilson JM. A novel adenovirus-adeno-associated
virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum
Gene Ther 1996;7:2079-87.
[126] Lieber A, Steinwarder DS, Carlson CA, Kay MA. Integrating adenovirus-adenoassoci-
ated virus hybrid vectors devoid of all genes. J Virol 1999;73:9314-24.
[127] Sandolon Z, Gnatenko DM, Bahou WF, Hearing P. Adeno-associated (AAV) rep protein
enhances the generation of a recombinant mini-adenovirus utilizing an Ad/ AAV hybrid
virus. J Virol 2000;74:10381-9.
[128] Johnston KM, Jacoby D, Pechan PA, Fraefel C, Borghesani P, Schuback D, et al. HSV/
AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum
Gen Ther 1997;8:359-70.